| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $13.6M | — | -43.0% |
| SG&A Expense | $5.4M | — | -32.4% |
| Operating Income | -$19.0M | — | +40.4% |
| Interest Expense | $331K | — | -18.5% |
| Net Income | -$17.9M | — | +41.7% |
| EPS (Basic) | -$0.17 | — | +70.7% |
| EPS (Diluted) | -$0.17 | — | +70.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $32.3M | +97.2% | +56.6% |
| Short-term Investments | $108.0M | +280.2% | +39.9% |
| Current Assets | $145.6M | +187.0% | +42.0% |
| Total Assets | $178.3M | +202.0% | +47.5% |
| Current Liabilities | $20.2M | -17.8% | +7.7% |
| Long-term Debt | $8.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$18.6M | — | +24.4% |
| Capital Expenditures | $50K | — | -16.7% |
| Investing Cash Flow | -$105.0M | — | -479.9% |
| Financing Cash Flow | $139.6M | — | — |
| Free Cash Flow | -$18.7M | — | +24.4% |
| -16.4% |
| Total Liabilities | $27.0M | -18.4% | -17.2% |
| Stockholders' Equity | $151.3M | +482.5% | +71.4% |